A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma
Translational Cancer Research · 2023-05 · 12 (5) · 1145-1164
DOI: 10.21037/tcr-22-2565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Cancer Research, 2023-05. Verfasst von Tianqi Lai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Liver cancer remains one of the tricky malignancies nowadays. GINS complex subunit 3 (GINS3), part of the GINS tetrameric complex, is significantly upregulated in many cancers, including liver hepatocellular carcinoma (LIHC). With the development of liver cancer treatment, immune and molecular targeted therapy gradually becomes a promising treatment. However, the key target for liver cancer is still indistinct. Herein, the underneath mechanism of GINS3 was investigated to verify its role as a biomarker in LIHC.
Methods
Genomic expression, genetic alteration, and methylation analyses were obtained from The Cancer Genome Atlas (TCGA), Clinical Proteomic Tumor Analysis Consortium (CPTAC), The University of Alabama at Birmingham CANcer (UALCN), and Human Protein Atlas (HPA), cBioPortal, and MethSurv databases. Subsequently, the diagnostic and prognostic role of GINS3 in LIHC were analyzed based on data from receiver operating characteristic (ROC), Kaplan-Meier plotter (KM-plotter), and univariate and multivariate cox regression analyses. The functional analyses were conducted with GeneMANIA and STRING databases, gene-gene, and protein-protein interaction (PPI) networks, Gene Ontology (GO) term, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Tumor Immune Estimation Resource (TIMER), Tumor-Immune System Interaction Database (TISIDB), and Gene Expression Profiling Interactive Analysis (GEPIA) were utilized to explore the internal connection with the immune escape.
Results
Through the analyses of genomic expression, GINS3 was significantly upregulated in LIHC and positively correlated with higher T classification. ROC analysis indicated GINS3 as a potential biomarker in the diagnosis of LIHC. KM-plotter, univariate and multivariate cox regression analyses both associated GINS3 with poor prognosis in LIHC patients. GINS3 genetic alteration, gene-gene interaction, PPI networks, and enrichment analysis further revealed that GINS3 played a pivotal role in the progression of LIHC. Furthermore, hypermethylation of GINS3 at different cytosine-guanine (CpG) sites was correlated with better or worse overall survival (OS) in LIHC and GINS3 was also closely correlated with m6A modification. Moreover, results supported that GINS3 could influence the tumor microenvironment and relate to the immune checkpoints.
Conclusions
Taken together, comprehensive analyses from this study supported GINS3 as a novel targeted biomarker in LIHC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.
- Department of Clinical Medicine, Medical College, Jinan University, Guangzhou, China.
- Department of Digestive Endoscopy, The First Affiliated Hospital, Jinan University, Guangzhou, China.
- Department of Pathophysiology, Medical College, Jinan University, Guangzhou, China.
- Department of General Surgery, The Affiliated Shunde Hospital, Jinan University, Foshan, China.
Zitieren
APA
Lai, T., Peng, T., Li, J., Jiang, Y., Liu, K., Yu, W., Yao, N., Hu, Y., Cao, M., & Liang, J. (2023). A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma. Translational Cancer Research, 12(5), 1145-1164. https://doi.org/10.21037/tcr-22-2565
Vancouver
Lai T, Peng T, Li J, Jiang Y, Liu K, Yu W, et al. A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma. Translational Cancer Research. 2023;12(5):1145-1164. doi:10.21037/tcr-22-2565
BibTeX
@article{Lai2023,
author = {Lai, Tianqi and Peng, Tianqi and Li, Jinying and Jiang, Yuchuan and Liu, Kangshou and Yu, Wei and Yao, Nan and Hu, Youzhu and Cao, Mingrong and Liang, Junjie},
title = {A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma},
journal = {Translational Cancer Research},
year = {2023},
volume = {12},
number = {5},
pages = {1145--1164},
doi = {10.21037/tcr-22-2565}
}
EUVIMED